
Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.
Publication
, Journal Article
Schneider, G; Reker, D; Chen, T; Hauenstein, K; Schneider, P; Altmann, K-H
Published in: Angewandte Chemie (International ed. in English)
September 2016
The cyclodepsipeptide doliculide is a marine natural product with strong actin-polymerizing and anticancer activities. Evidence for doliculide acting as a potent and subtype-selective antagonist of prostanoid E receptor 3 (EP3) is presented. Computational target prediction suggested that this membrane receptor is a likely macromolecular target and enabled immediate in vitro validation. This proof-of-concept study demonstrates the in silico deorphanization of phenotypic screening hits as a viable concept for future natural-product-inspired chemical biology and drug discovery efforts.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Angewandte Chemie (International ed. in English)
DOI
EISSN
1521-3773
ISSN
1433-7851
Publication Date
September 2016
Volume
55
Issue
40
Start / End Page
12408 / 12411
Related Subject Headings
- Receptors, Prostaglandin E, EP3 Subtype
- Organic Chemistry
- Ligands
- Kinetics
- Humans
- HEK293 Cells
- Drug Design
- Depsipeptides
- Biological Products
- 03 Chemical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Schneider, G., Reker, D., Chen, T., Hauenstein, K., Schneider, P., & Altmann, K.-H. (2016). Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. Angewandte Chemie (International Ed. in English), 55(40), 12408–12411. https://doi.org/10.1002/anie.201605707
Schneider, Gisbert, Daniel Reker, Tao Chen, Kurt Hauenstein, Petra Schneider, and Karl-Heinz Altmann. “Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.” Angewandte Chemie (International Ed. in English) 55, no. 40 (September 2016): 12408–11. https://doi.org/10.1002/anie.201605707.
Schneider G, Reker D, Chen T, Hauenstein K, Schneider P, Altmann K-H. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. Angewandte Chemie (International ed in English). 2016 Sep;55(40):12408–11.
Schneider, Gisbert, et al. “Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.” Angewandte Chemie (International Ed. in English), vol. 55, no. 40, Sept. 2016, pp. 12408–11. Epmc, doi:10.1002/anie.201605707.
Schneider G, Reker D, Chen T, Hauenstein K, Schneider P, Altmann K-H. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. Angewandte Chemie (International ed in English). 2016 Sep;55(40):12408–12411.

Published In
Angewandte Chemie (International ed. in English)
DOI
EISSN
1521-3773
ISSN
1433-7851
Publication Date
September 2016
Volume
55
Issue
40
Start / End Page
12408 / 12411
Related Subject Headings
- Receptors, Prostaglandin E, EP3 Subtype
- Organic Chemistry
- Ligands
- Kinetics
- Humans
- HEK293 Cells
- Drug Design
- Depsipeptides
- Biological Products
- 03 Chemical Sciences